Tempus
NASDAQ: TEMUnicorn · $5.9BChicago, US · Founded 2015 · 11 known investors
Find your way into Tempus
Sign up to see every warm intro you have to Tempus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tempus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas. The company operates a technology platform that connects healthcare institutions to aggregate and analyze multimodal patient data, serving physicians, pharmaceutical companies, and healthcare systems seeking to optimize therapy selection and drug development.
Founders & leadership
Tempus was founded in 2015 by Eric Lefkofsky.


Board

Investors · 11
How we know: Caesar Ventures's portfolio page · Not right? Tell us
How we know: Khosla Ventures's portfolio page · Not right? Tell us
How we know: Lightbank's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: New Enterprise Associates (NEA)'s portfolio page · board seat on SEC Form D · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Revolution's portfolio page · the S-1 prospectus · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$271M disclosed across 4 of 5 rounds · 2017–2022
▶$10MraisedOct 2022 · 4 investors · OtherRule 506(b)
- ROBERT GHENCHEVDirector
- JENNIFER DOUDNADirector
- WAYNE FREDERICKDirector
- PETER BARRISDirector
- SCOTT GOTTLIEBDirector
- ERIK PHELPSExecutive Officer
- TED LEONSISDirector
- ERIC BELCHERDirector
- NADJA WESTDirector
- JIM ROGERSExecutive Officer
- ERIC LEFKOFSKYExecutive Officer, Director
- RYAN FUKUSHIMAExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$111MraisedSep 2018 · 16 investors · OtherRule 506(b)
- Eric LefkofskyExecutive Officer, Director
- Ryan FukushimaExecutive Officer
- Peter BarrisDirector
- Brad KeywellDirector
- Erik PhelpsExecutive Officer
- Offering amount
- $111M
- Amount sold
- $111M
- Sales commissions
- $2.2M
- Placement agents
- Allen & Company LLC
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$80MraisedMar 2018 · 16 investors · OtherRule 506(b)
- Erik PhelpsExecutive Officer
- Peter BarrisDirector
- Ryan FukushimaExecutive Officer
- Brad KeywellDirector
- Eric LefkofskyExecutive Officer, Director
- Offering amount
- $100M
- Amount sold
- $80M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$70MraisedSep 2017 · 4 investors · OtherRule 506(b)
- Brad KeywellDirector
- Peter BarrisDirector
- Erik PhelpsExecutive Officer
- Eric LefkofskyExecutive Officer, Director
- Ryan FukushimaExecutive Officer
- Offering amount
- $70M
- Amount sold
- $70M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Tempus went on to found or lead other companies.
Frequently asked questions
- What does Tempus do?
- Tempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas. The company operates a technology platform that connects healthcare institutions to aggregate and analyze multimodal patient data, serving physicians, pharmaceutical companies, and healthcare systems seeking to optimize therapy selection and drug development.
- Who founded Tempus?
- Tempus was founded by Eric Lefkofsky in 2015.
- Who are Tempus's investors?
- Tempus's investors include Caesar Ventures, Compound, FPV, Khosla Ventures, Lightbank, Lingotto, New Enterprise Associates (NEA), Revolution and 3 more.
- How much funding has Tempus raised?
- Tempus has disclosed $271M raised across 4 of its 5 known rounds.
- Where is Tempus headquartered?
- Tempus is headquartered in Chicago, US.



